| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | KPTI | Common Stock | Sale | $3,369 | -2,545 | -1% | $1.32 | 244,400 | 27 Feb 2024 | Direct | F1 |
| transaction | KPTI | Common Stock | Award | $0 | +188,205 | +77% | $0.000000 | 432,605 | 28 Feb 2024 | Direct | F2 |
| Id | Content |
|---|---|
| F1 | This transaction was effected pursuant to a durable automatic sale instruction plan adopted by the reporting person on June 10, 2021, and represents a broker-assisted sale of shares to satisfy the payment of withholding tax liability incurred upon the vesting of restricted stock units ("RSUs"). The sale does not represent a discretionary trade by the reporting person. |
| F2 | Represents the award of RSUs pursuant to the Karyopharm Therapeutics Inc. 2022 Equity Incentive Plan, as amended. RSUs convert into Karyopharm Therapeutics Inc. common stock on a one-for-one basis. The RSUs vest in three equal annual installments beginning February 28, 2025. |